Annual General Meeting
Released
Released
Announcement PDF
ASX Announcement
1 December 2021
Annual General Meeting
Biome Australia Limited (ASX:BIO, “Biome” or “the Company”), the microbiome health company,
wishes to remind shareholders that the shareholder meeting is scheduled to be held on Friday,
10 December 2021 at 9:30am (AEDST) (Meeting).
In light of the current circumstances and continued uncertainty on restrictions on gatherings, the
Directors made the decision to hold the Meeting virtually. Accordingly, there will not be a physical
location where shareholders can attend the Meeting in person.
In accordance with the Treasury Laws Amendment (2021 Measures No. 1) Act 2021, the
Company has not sent hard copies of the Notice of Meeting to shareholders unless a shareholder
has previously requested a hard copy. The Notice of Meeting can be viewed and downloaded
from the following link: Notice of Meeting.
Shareholders are encouraged to vote online at https://investor.automic.com.au/#/loginsah or by
returning the enclosed proxy form by:
Post to: Automic GPO Box 5193 Sydney NSW 2001
Email to: meetings@automicgroup.com.au
The Company strongly encourages Shareholders to lodge a directed proxy form prior to
the meeting.
If you have nominated an email address and have elected to receive electronic communications
from the Company, you would have also received an email to your nominated email address with
a link to an electronic copy of the important Meeting documents.
Your proxy voting instruction must be received by 9:30am (AEDST) on Wednesday 8 December
2021, being not less than 48 hours before the commencement of the Meeting. Any proxy voting
instructions received after that time will not be valid for the Meeting.
Questions must be submitted in writing to George Lazarou, the Company Secretary at
george@activated.co at least 48 hours before the Meeting, as this will provide management with
the best opportunity to prepare for the Meeting, for example, by preparing answers in advance to
Shareholders questions.
Shareholders who wish to attend virtually and vote on the day of the Meeting will need to login to
register by going to the following link: Click on this link to register.
In order to receive electronic communications from the Company in the future, please update your
Shareholder details online at https://www-https://www.automicgroup.com.au/investor.
If you are unable to access any of the important Meeting documents online, please contact the
Company Secretary, George Lazarou, on (03) 8617 8014 or via email at george@activated.co.
The Australian government and the respective State governments are implementing a wide range
of measures to contain or delay the spread of COVID-19. If it becomes necessary or appropriate
to make alternative arrangements to those set out in the Company’s Notice of Meeting, the
Company will notify Shareholders accordingly via the Company’s website at
https://biomeaustralia.com/ and the Company’s ASX Announcement Platform at asx.com.au
(ASX: BIO).
-–ENDS–
About the microbiome
The microbiome is the genetic material of all the microbes – bacteria, fungi, protozoa and viruses
– that live on and inside the human body. The relationship between the gut microbiome and
human health is an active and rapidly advancing area of research and complementary medicine.
Probiotics are foods or supplements that contain live micro-organisms intended to maintain or
improve the ‘good’ bacteria in the body.
About Biome Australia
Founded in Australia in 2018, Biome Australia develops, licenses and markets innovative,
evidence-based strain-specific probiotics and complementary medicines, with the health benefits
of Biome's Activated Probiotics® products supported by clinical research. Biome aims to prevent
disease, improve health outcomes and quality of life, and make its products accessible to all.
Activated Probiotics® is a range of live biotherapeutic (probiotic) products clinically researched to
help prevent and support the management of various health concerns, including mood and sleep,
bone health, iron malabsorption, mild eczema and IBS, a number of which are supported by
randomised double-blind placebo-controlled trials.
Biome also developed and distributes a number of formulated, organic nutraceuticals under its
brand, Activated Nutrients® and a sports performance and recovery range, Activated X
Performance®, which is targeted at professional athletes.
For more information visit: www.biomeaustralia.com
Investor enquiries
cosec@activated.co
Media enquiries
media@activated.co
Share your feedback
Discover